Trinity Biotech (TRIB) Registration Filing summary

Management team and governance

• CEO is John Gillard, who also serves as principal executive officer and company secretary.

• Louise Tallon is the Chief Financial Officer.

• Board includes directors James Walsh, Ronan O'Caoimh, Thomas Lindsay, and Andrew Omidvar.

• Directors and officers are indemnified against liabilities incurred in their official capacity, with agreements in place and insurance coverage where applicable.

Offering details and pricing

• Registration statement filed to allow for the sale of securities from time to time after the effective date.

• Securities may be offered on a delayed or continuous basis under Rule 415.

• The registration statement may be amended to reflect material changes or to include required financial statements.

Underwriters and syndicate

• Craig-Hallum Capital Group LLC engaged as financial advisor under a non-exclusive agreement.

• Advisor compensated with a $1,124,500 non-refundable retainer, payable in cash or 650,000 American Depository Shares (ADSs).

• Advisor is an accredited investor and subject to resale restrictions and volume limitations.

• Company must file a resale registration statement for the advisor's shares and may owe liquidated damages for delays.